Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are creating turbulence within the Pharma sector.

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

RSV vaccines could get broader CDC backing for adults aged 50-59 at risk after an endorsement from an agency's expert panel. Read more here.

GSK (GSK) said it is “pleased” that the Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines ...

GSK plc (NYSE:GSK) is advancing several promising ... 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap ...

In this article, we are going to take a look at where GSK ... the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap ...

could cause cancer were “admissible”, sparking a sell-off in GSK shares that wiped billions off its market cap. Now, the drugmaker and co-defendants, including Pfizer, Sanofi, and Boehringer ...

Shares of GSK PLC GSK slipped 6.07% to £13.32 Monday, on what proved to be an all-around rough trading session for the stock ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

GSK market cap is currently £59.69B and has a P/E ratio of 23.26. Based on the recent corporate insider activity of 311 insiders, corporate insider sentiment is negative on the stock. This means ...